Heart Disease & Genomics: What's Next?
CDC information: Genomics and heart disease
Genetics and Genomics for the Prevention and Treatment of Cardiovascular Disease: Update: A scientific statement from the American Heart Association Circulation December 2013
2013 ACC/AHA guideline on the assessment of cardiovascular risk
Circulation. November 2013
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults
Circulation. November 2013
- "The guideline recognizes that adults with primary, severe elevations of LDL–C (≥190 mg/dL) have a high lifetime risk for heart related events. This is due to their lifetime exposure to markedly elevated LDL–C levels arising from genetic causes."
- "Because the hypercholesterolemia in these high-risk individuals is often genetically determined (e.g. familial hypercholesterolemia), family screening is especially important in this group to identify additional family members who would benefit from assessment and early treatment."
No hay comentarios:
Publicar un comentario